Results 71 to 80 of about 22,413 (206)
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews +3 more
wiley +1 more source
Management of Intrauterine Device Migrated into the Bladder: A Case Report and Literature Review
Intrauterine device represents the most reversible method of contraceptive worldwide. Its insertion is a medical procedure not free from complication.
A. K. Paré +6 more
doaj +1 more source
Family Planning Market in India [PDF]
This literature review captures existing knowledge across a range of products and players in India's family planning market. The product scope covers condoms, oral contraceptive pills, injectable contraceptives, intra-uterine devices, and male and female
Laura Amaya +2 more
core
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis [PDF]
Objectives: To evaluate the risk of venous thromboembolic events associated with the use of progestin-only contraception and whether that risk differs with the mode of drug delivery (oral, intrauterine, or depot injection).
Bauer, Kenneth Alan +5 more
core +1 more source
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 421-423, April 2025.
Peter H. Cygan +3 more
wiley +1 more source
ABSTRACT Surgical menopause, the removal of both ovaries prior to natural menopause, may impact short‐and long‐term physical and emotional health. An increasingly common cause of surgical menopause is risk‐reducing salpingo‐oophorectomy (RRSO) in those at high inherited risk of ovarian cancer.
Sarah A. L. Price +12 more
wiley +1 more source
Intraperitoneal migration of an intrauterine device. [PDF]
Intrauterine devices (IUD) are one of the most common contraceptive methods worldwide. Although adverse events from their use are low, their insertion can cause some complications.
Nabila FEGHOUL +3 more
doaj +1 more source
Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration [PDF]
The subdermal contraceptive implant, and the 52mg levonorgestrel intrauterine device (IUD) are currently FDA-approved for three and five years of use respectively. Limited available data has suggested both of these methods are effective beyond that time.
McNicholas, Colleen +3 more
core +1 more source
Intensive lifestyle interventions‐based weight management targeting fat reduction may enhance fertility‐sparing treatment outcomes in overweight patients with endometrial cancer or its precursor. Our findings advocate the integration of body composition‐guided weight management into standardized protocols.
Sijia Liu +10 more
wiley +1 more source
An Analysis of the Majority Report “Responsible Parenthood” and its Recommendations on Abortion, Sterilization and Contraception [PDF]
This paper will focus on the majority report (titled “Responsible Parenthood”) of the 1966 Papal Birth Control Commission and its recommendations on abortion, sterilization, and contraception.(1) The analysis is made with the hindsight and perspective of
Fehring, Richard
core +1 more source

